Sell Arena Pharmaceuticals And Step To The Sidelines [View article]
Hey Shane; Can you guide me on Amrin? I average $12.36/Share. Do I keep it, or sell some at a certain price? I personally think Amrin have better chance than most other drug. Thanks man
Amarin: An Opportunity To Add To The Position [View article]
Honest view, and I agree. I was happy to add on $8.45. I expect to be rewarded by Feb. next yr, if not I am OK after all these wait to be long on AMRN.
Amarin (AMRN) announces $100M in non-equity financing with an investment fund managed by Pharmakon Advisors, and that it's continuing preparations to commercialize Vascepa capsules by hiring a sales force in the United States. Payments under this hybrid debt-like instrument are expected to be made over a 3.5-year period commencing in November 2013 and to continue through early 2017. Shares -21% AH. [View news story]
I think we need to hang longer than what we were anticipating.
Amarin (AMRN) announces $100M in non-equity financing with an investment fund managed by Pharmakon Advisors, and that it's continuing preparations to commercialize Vascepa capsules by hiring a sales force in the United States. Payments under this hybrid debt-like instrument are expected to be made over a 3.5-year period commencing in November 2013 and to continue through early 2017. Shares -21% AH. [View news story]
Wishful thinking, I am long Amrn, it looks like Amrn knows this will not happen, that's why AMRN raised money to go alone. Any feed back will be helpful.
Dare I Say Amarin Looks Bullish On Good News? [View article]
My 5 Summer Stock Market Flings For 2013 [View article]
Long Amrn
Is Keryx Biopharmaceuticals A Good Buy At $9+? [View article]
Is Keryx Biopharmaceuticals A Good Buy At $9+? [View article]
A) why did public offering was $8.29-$8.50/share, if there is down trend / Risk?
B) why big banks are behind their KERX financing etc?
Thanks you for your feed back.
Is Keryx Biopharmaceuticals A Good Buy At $9+? [View article]
Epic Pair Trade: Go Long Apple And Short RIM [View article]
Why Investors May Have To Reconsider Priceline.com [View article]
My 1st Quarter 2013 Apple Double Income Stream Strategy [View article]
How Apple Gets To $400 A Share [View article]
Sell Arena Pharmaceuticals And Step To The Sidelines [View article]
Do I keep it, or sell some at a certain price? I personally think Amrin have better chance than most other drug. Thanks man
Amarin Trades Super Bearish Ahead Of Vascepa Launch [View article]
Hscheib thanks for the link.
Amarin: An Opportunity To Add To The Position [View article]
Amarin (AMRN) announces $100M in non-equity financing with an investment fund managed by Pharmakon Advisors, and that it's continuing preparations to commercialize Vascepa capsules by hiring a sales force in the United States. Payments under this hybrid debt-like instrument are expected to be made over a 3.5-year period commencing in November 2013 and to continue through early 2017. Shares -21% AH. [View news story]
Amarin (AMRN) announces $100M in non-equity financing with an investment fund managed by Pharmakon Advisors, and that it's continuing preparations to commercialize Vascepa capsules by hiring a sales force in the United States. Payments under this hybrid debt-like instrument are expected to be made over a 3.5-year period commencing in November 2013 and to continue through early 2017. Shares -21% AH. [View news story]
Conflicting Trading Activity On Amarin As Catalysts Approach [View article]